Agios Pharmaceuticals
AGIO
#4274
Rank
A$3.22 B
Marketcap
$56.59
Share price
-1.09%
Change (1 day)
60.76%
Change (1 year)

P/E ratio for Agios Pharmaceuticals (AGIO)

P/E ratio as of December 2024 (TTM): -8.97

According to Agios Pharmaceuticals 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -8.96709. At the end of 2022 the company had a P/E ratio of -6.62.

P/E ratio history for Agios Pharmaceuticals from 2013 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-6.62-548.09%
20211.48-116.17%
2020-9.1431.52%
2019-6.95-9.11%
2018-7.65-9.85%
2017-8.482.65%
2016-8.26-60.16%
2015-20.7-70.75%
2014-70.9389.02%
2013-14.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-11.3 25.75%๐Ÿ‡บ๐Ÿ‡ธ USA
118-1,410.44%๐Ÿ‡บ๐Ÿ‡ธ USA
14.2-258.04%๐Ÿ‡บ๐Ÿ‡ธ USA
84.3-1,040.37%๐Ÿ‡บ๐Ÿ‡ธ USA
9.60-207.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
141-1,677.00%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.